SRI International, an independent nonprofit research institute, has named Kathlynn Brown to President of its Biosciences Division B.
SRI International Appoints Kathlynn Brown to Biosciences Division President
MENLO PARK, Calif., Jan. 5, 2022 /PRNewswire/ -- SRI International (SRI) today announced the company has entered into a collaboration agreement with Janssen Pharmaceutica NV (Janssen), one of the Janssen Pharmaceutical Companies of Johnson & Johnson. Under the terms of the agreement, the organizations and their scientists will leverage SRI's SynFiniTM platform, an artificial intelligence (Al)-guided, automated synthetic- chemistry system for small molecule drug discovery. The agreement was facilitated by Johnson & Johnson Innovation.